Male infertility as a proxy of the overall male health status

P Capogrosso, E Ventimiglia, Luca Boeri, W Cazzaniga, F Chierigo, F Montorsi, A Salonia

Research output: Contribution to journalArticle

Abstract

INTRODUCTION: Male infertility (MI) has been widely associated with different comorbid conditions. The aim of this review is to summarize the available evidences investigating the link between MI cancer, chronic non-malignant conditions and overall health. EVIDENCE ACQUISITION: A literature search has been conducted using the MEDLINE/PubMed and Scopus databases for English-language original and review articles and selecting publications from January 2007 to June 2017, although highly regarded older publications were also considered. The following key words and MeSH terms were combined: “male infertility,” “semen analysis,” “health,” “comorbidities,” “cancer,” “metabolic syndrome,” “diabetes,” “hypertension,” “cardiovascular diseases,” and “mortality.” EVIDENCE SYNTHESIS: Several studies supported a higher risk of testis cancer for patients with MI; conversely, controversial findings have been reported on the association between prostate cancer and MI. Beside urogenital malignancies, melanoma, bladder, thyroid and hematological malignancies have been also more frequently reported among infertile men. Large cohort studies supported a significant association between diabetes mellitus, metabolic disorders and MI. Similarly, the risk of developing cardiovascular diseases appears to be higher among infertile men. Of note, a significant association between semen alterations and the overall burden of comorbidities, as well as the overall mortality, has been reported. A common genetic background appears as the main pathophysiological link between infertility and other comorbidities. CONCLUSIONS: Male infertility is a proxy of the overall male health status. Physicians should comprehensively assess men presenting for couple infertility and properly followed-up these patients given their higher risk of developing cancer. © 2018 EDIZIONI MINERVA MEDICA.
Original languageEnglish
Pages (from-to)286-299
Number of pages14
JournalMinerva Urologica e Nefrologica
Volume70
Issue number3
Publication statusPublished - 2018

Fingerprint

Male Infertility
Proxy
Health Status
Comorbidity
Infertility
Publications
Neoplasms
Cardiovascular Diseases
Semen Analysis
Mortality
Testicular Neoplasms
Health
Hematologic Neoplasms
Semen
PubMed
MEDLINE
Melanoma
Prostatic Neoplasms
Diabetes Mellitus
Thyroid Gland

Cite this

Capogrosso, P., Ventimiglia, E., Boeri, L., Cazzaniga, W., Chierigo, F., Montorsi, F., & Salonia, A. (2018). Male infertility as a proxy of the overall male health status. Minerva Urologica e Nefrologica, 70(3), 286-299.

Male infertility as a proxy of the overall male health status. / Capogrosso, P; Ventimiglia, E; Boeri, Luca; Cazzaniga, W; Chierigo, F; Montorsi, F; Salonia, A.

In: Minerva Urologica e Nefrologica, Vol. 70, No. 3, 2018, p. 286-299.

Research output: Contribution to journalArticle

Capogrosso, P, Ventimiglia, E, Boeri, L, Cazzaniga, W, Chierigo, F, Montorsi, F & Salonia, A 2018, 'Male infertility as a proxy of the overall male health status', Minerva Urologica e Nefrologica, vol. 70, no. 3, pp. 286-299.
Capogrosso P, Ventimiglia E, Boeri L, Cazzaniga W, Chierigo F, Montorsi F et al. Male infertility as a proxy of the overall male health status. Minerva Urologica e Nefrologica. 2018;70(3):286-299.
Capogrosso, P ; Ventimiglia, E ; Boeri, Luca ; Cazzaniga, W ; Chierigo, F ; Montorsi, F ; Salonia, A. / Male infertility as a proxy of the overall male health status. In: Minerva Urologica e Nefrologica. 2018 ; Vol. 70, No. 3. pp. 286-299.
@article{58bcef35ee20408992c323b52bb424e5,
title = "Male infertility as a proxy of the overall male health status",
abstract = "INTRODUCTION: Male infertility (MI) has been widely associated with different comorbid conditions. The aim of this review is to summarize the available evidences investigating the link between MI cancer, chronic non-malignant conditions and overall health. EVIDENCE ACQUISITION: A literature search has been conducted using the MEDLINE/PubMed and Scopus databases for English-language original and review articles and selecting publications from January 2007 to June 2017, although highly regarded older publications were also considered. The following key words and MeSH terms were combined: “male infertility,” “semen analysis,” “health,” “comorbidities,” “cancer,” “metabolic syndrome,” “diabetes,” “hypertension,” “cardiovascular diseases,” and “mortality.” EVIDENCE SYNTHESIS: Several studies supported a higher risk of testis cancer for patients with MI; conversely, controversial findings have been reported on the association between prostate cancer and MI. Beside urogenital malignancies, melanoma, bladder, thyroid and hematological malignancies have been also more frequently reported among infertile men. Large cohort studies supported a significant association between diabetes mellitus, metabolic disorders and MI. Similarly, the risk of developing cardiovascular diseases appears to be higher among infertile men. Of note, a significant association between semen alterations and the overall burden of comorbidities, as well as the overall mortality, has been reported. A common genetic background appears as the main pathophysiological link between infertility and other comorbidities. CONCLUSIONS: Male infertility is a proxy of the overall male health status. Physicians should comprehensively assess men presenting for couple infertility and properly followed-up these patients given their higher risk of developing cancer. {\circledC} 2018 EDIZIONI MINERVA MEDICA.",
author = "P Capogrosso and E Ventimiglia and Luca Boeri and W Cazzaniga and F Chierigo and F Montorsi and A Salonia",
year = "2018",
language = "English",
volume = "70",
pages = "286--299",
journal = "Minerva Urologica e Nefrologica",
issn = "0393-2249",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "3",

}

TY - JOUR

T1 - Male infertility as a proxy of the overall male health status

AU - Capogrosso, P

AU - Ventimiglia, E

AU - Boeri, Luca

AU - Cazzaniga, W

AU - Chierigo, F

AU - Montorsi, F

AU - Salonia, A

PY - 2018

Y1 - 2018

N2 - INTRODUCTION: Male infertility (MI) has been widely associated with different comorbid conditions. The aim of this review is to summarize the available evidences investigating the link between MI cancer, chronic non-malignant conditions and overall health. EVIDENCE ACQUISITION: A literature search has been conducted using the MEDLINE/PubMed and Scopus databases for English-language original and review articles and selecting publications from January 2007 to June 2017, although highly regarded older publications were also considered. The following key words and MeSH terms were combined: “male infertility,” “semen analysis,” “health,” “comorbidities,” “cancer,” “metabolic syndrome,” “diabetes,” “hypertension,” “cardiovascular diseases,” and “mortality.” EVIDENCE SYNTHESIS: Several studies supported a higher risk of testis cancer for patients with MI; conversely, controversial findings have been reported on the association between prostate cancer and MI. Beside urogenital malignancies, melanoma, bladder, thyroid and hematological malignancies have been also more frequently reported among infertile men. Large cohort studies supported a significant association between diabetes mellitus, metabolic disorders and MI. Similarly, the risk of developing cardiovascular diseases appears to be higher among infertile men. Of note, a significant association between semen alterations and the overall burden of comorbidities, as well as the overall mortality, has been reported. A common genetic background appears as the main pathophysiological link between infertility and other comorbidities. CONCLUSIONS: Male infertility is a proxy of the overall male health status. Physicians should comprehensively assess men presenting for couple infertility and properly followed-up these patients given their higher risk of developing cancer. © 2018 EDIZIONI MINERVA MEDICA.

AB - INTRODUCTION: Male infertility (MI) has been widely associated with different comorbid conditions. The aim of this review is to summarize the available evidences investigating the link between MI cancer, chronic non-malignant conditions and overall health. EVIDENCE ACQUISITION: A literature search has been conducted using the MEDLINE/PubMed and Scopus databases for English-language original and review articles and selecting publications from January 2007 to June 2017, although highly regarded older publications were also considered. The following key words and MeSH terms were combined: “male infertility,” “semen analysis,” “health,” “comorbidities,” “cancer,” “metabolic syndrome,” “diabetes,” “hypertension,” “cardiovascular diseases,” and “mortality.” EVIDENCE SYNTHESIS: Several studies supported a higher risk of testis cancer for patients with MI; conversely, controversial findings have been reported on the association between prostate cancer and MI. Beside urogenital malignancies, melanoma, bladder, thyroid and hematological malignancies have been also more frequently reported among infertile men. Large cohort studies supported a significant association between diabetes mellitus, metabolic disorders and MI. Similarly, the risk of developing cardiovascular diseases appears to be higher among infertile men. Of note, a significant association between semen alterations and the overall burden of comorbidities, as well as the overall mortality, has been reported. A common genetic background appears as the main pathophysiological link between infertility and other comorbidities. CONCLUSIONS: Male infertility is a proxy of the overall male health status. Physicians should comprehensively assess men presenting for couple infertility and properly followed-up these patients given their higher risk of developing cancer. © 2018 EDIZIONI MINERVA MEDICA.

M3 - Article

VL - 70

SP - 286

EP - 299

JO - Minerva Urologica e Nefrologica

JF - Minerva Urologica e Nefrologica

SN - 0393-2249

IS - 3

ER -